The use of fibrinogen concentrate to disseminated intravascular coagulation during obstetric haemorrhage

The use of fibrinogen concentrate to disseminated intravascular coagulation during obstetric haemorrhage - The use of fibrinogen concentrate to disseminated intravascular coagulation during obstetric haemorrhage

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010540

Enrollment

Registered

2013-06-01

Start date

2013-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

disseminated intravascular coagulation

Interventions

intravenous administration of concentrate fibrinogen

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: hypofibrinogenaemia induced by postpartum massive haemorrage

Exclusion criteria

Exclusion criteria: compromised host

Design outcomes

Primary

Measure	Time frame
Whether maternal life could be saved or not.	—

Countries

Japan

Contacts

Public ContactKaoru Kawasaki

Kyoto university Graduate School of Medicine Obstetrics and gynecology

kkaoru@kuhp.kyoto-u.ac.jp075-751-3269

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026